









Markets
/
Stocks
/
nasdaq-cbio
/

Crescent Biopharma Ord Shs

CBIO

15.310USD

+0.820+5.66%

Close 12/11, 16:00（ET）Quotes delayed by 15 min

212.69MMarket Cap

LossP/E TTM



Crescent Biopharma Ord Shs

15.310

+0.820+5.66%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of Crescent Biopharma Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Total equity

Cash, cash equivalents and short-term investments

--133.26M

- Cash and cash equivalents

--133.26M

Prepaid expenses

--1.30M

Total current assets

--134.56M

Non-current assets

Net Fixed Assets

--2.35M

Other non-current assets

--1.36M

Total non-current assets

--3.71M

Total assets

--138.27M

Liabilities

Current liabilities

-Other payables

--8.36M

Accrued expenses

--8.96M

Other current liabilities

--8.36M

Total current liabilities

--20.30M

Non-current liabilities

Long-term debt and lease liabilities

--1.32M

-Long-term debt

--0.00

-Long-term lease liabilities

--1.32M

Total non-current liabilities

--1.32M

Total liabilities

--21.63M

Shareholders' equity

Common equity

--192.05M

Retained earnings

---79.41M

Capital reserves

--192.04M

Total equity

--116.64M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

